Semi-Annual Consolidated Balance Sheet

Carna Biosciences, Inc. - Filing #7586726

Concept As at
2022-09-30
As at
2021-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,727,485,000 JPY
3,817,834,000 JPY
Other
414,550,000 JPY
146,324,000 JPY
Current assets
4,367,170,000 JPY
5,318,487,000 JPY
Non-current assets
Property, plant and equipment
110,988,000 JPY
51,574,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
2,120,000 JPY
2,738,000 JPY
Investments and other assets
67,459,000 JPY
59,760,000 JPY
Investments and other assets
Non-current assets
180,568,000 JPY
114,073,000 JPY
Assets
4,547,738,000 JPY
5,432,560,000 JPY
Liabilities
Current liabilities
Income taxes payable
17,527,000 JPY
24,236,000 JPY
Other
16,139,000 JPY
200,794,000 JPY
Current liabilities
370,203,000 JPY
774,655,000 JPY
Non-current liabilities
Bonds payable
JPY
32,000,000 JPY
Long-term borrowings
178,399,000 JPY
268,390,000 JPY
Asset retirement obligations
37,888,000 JPY
37,434,000 JPY
Other
17,978,000 JPY
4,508,000 JPY
Non-current liabilities
234,266,000 JPY
342,332,000 JPY
Liabilities
604,470,000 JPY
1,116,988,000 JPY
Net assets
Share capital
1,231,110,000 JPY
1,056,953,000 JPY
Shareholders' equity
Capital surplus
4,982,320,000 JPY
4,808,163,000 JPY
Retained earnings
-2,368,169,000 JPY
-1,572,951,000 JPY
Treasury shares
-222,000 JPY
-222,000 JPY
Shareholders' equity
3,845,039,000 JPY
4,291,942,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-2,347,000 JPY
-630,000 JPY
Deferred gains or losses on hedges
37,366,000 JPY
6,578,000 JPY
Foreign currency translation adjustment
55,210,000 JPY
7,841,000 JPY
Valuation and translation adjustments
90,229,000 JPY
13,789,000 JPY
Share acquisition rights
7,999,000 JPY
9,840,000 JPY
Net assets
3,943,268,000 JPY
4,315,572,000 JPY
Liabilities and net assets
4,547,738,000 JPY
5,432,560,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.